Mariola Gajewska
Popular Articles
Warburg Pincus-led group to buy in to PANTHERx Rare, I Squared to sell TIP...
A Warburg Pincus-led investor group has agreed to acquire a controlling interest in US rare disease pharmacy PANTHERx Rare from Nautic Partners, General Atlantic and The Vistria Group, with Nautic and management retaining significant stakes.
DELTA Equity Partners hits €125m hard cap for second buy-and-build fund
Dutch lower mid-market investor DELTA Equity Partners has raced to a final close of its second flagship fund on its €125m hard cap, just four months after launching the vehicle.
Pictet raises $253m for debut environment co-investment fund
Pictet Alternative Advisors has beaten its target for its first dedicated environmental private equity co-investment fund, securing $253m in commitments.
Citation Capital closes $1.2bn debut fund as emerging manager bucks fundraising headwinds
Citation Capital has held a $1.2bn final close for its inaugural private equity fund, making it one of the largest first-time buyout vehicles raised in recent years despite a difficult fundraising environment for new managers.
Lightspring Capital closes $218m second fund as lower mid-market specialist expands SBIC platform
Lightspring Capital Partners has held the final close of its second flagship fund on just over $218m, strengthening its position in the US lower middle market.
Deal Roundup: Wynnchurch agrees $1.6bn FloWorks sale, Archimed completes $1.1bn Esperion take-private
Wynnchurch Capital has agreed to sell industrial flow control distributor FloWorks to Ferguson Enterprises in a cash deal valuing the business at approximately $1.6bn.
Warren Equity Partners hits $2.8bn hard cap close for new flagship fund
Florida-based infrastructure investor Warren Equity Partners has closed its fifth flagship fund on about $2.8bn, exceeding its $2.25bn target and reaching its hard cap in less than a year.
Sofinnova Partners strengthens crossover investing team with Roche Venture’s David Evans
European life sciences VC investor Sofinnova Partners has appointed former Roche Venture Fund senior investment director David Evans as a partner, strengthening its late-stage investment capabilities as the firm continues to expand its crossover investing strategy.
Acurio Ventures closes €115m debut VC secondaries fund, two years after rebrand from All...
Acurio Ventures has held the final close of its debut venture capital secondaries fund on €115m, two years after the Spain-based investor rebranded from All Iron Ventures.
HarbourVest closes $4.75bn co-invest fund after exceeding target
HarbourVest Partners has closed its seventh flagship direct co-investment programme on about $4.75bn, comfortably surpassing its $4bn target.
